benserazide hydrochloride
PolandDrugs containing this active substance
-
Madopar is used in the treatment of Parkinson's disease. Some of its formulations are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.
Form: capsules
Active substance Dosage levodopa 50 mg benserazide hydrochloride 12.5 mg ATC: N04BA02
Manufacturer: Roche Pharma AG
-
Madopar is used in the treatment of Parkinson's disease and in the symptomatic treatment of restless legs syndrome (RLS), including in patients with renal failure requiring dialysis therapy.
Form: capsules
Active substance Dosage levodopa 100 mg benserazide hydrochloride 28.5 mg ATC: N04BA02
Manufacturer: Roche Pharma AG